Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host

By sjmartinez • January 5, 2024

Winston DJ, Young PA, Schlamm HT, Schiller GJ. Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host. Clin Infect Dis. 2024 Jan 4:ciad769. doi: 10.1093/cid/ciad769. Epub ahead of print. PMID: 38174352.

Tags: Hematology/Oncology, Publications

Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer

Silverstein J, Smick A, Johnson B, Konecny GE. Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Future Oncol. 2025[...]

DNA methylation patterns in breast cancer, paired benign tissue from ipsilateral and contralateral breast, and healthy controls

Dennis SR, Tsukioki T, Cottone G, Zhou W, Ganz PA, Sehl ME, Luo Y, Khan SA, Clare S. DNA methylation patterns in breast cancer, paired[...]

Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or Lymphomas

Harrington KJ, Champiat S, Brody JD, Cho BC, Romano E, Golan T, Hyngstrom JR, Strauss J, Oh DY, Popovtzer A, Gomez-Roca C, Perets R, Kim[...]